Discontinued — last reported Q4 '25
Income Before Tax
Pre-Tax Income (Foreign)
Vertex Pharmaceuticals Pre-Tax Income (Foreign) remained flat by 0.0% to $455.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.6%, from $404.55M to $455.50M. Over 2 years (FY 2023 to FY 2025), Pre-Tax Income (Foreign) shows an upward trend with a 18.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionIncome Before Tax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2015
Last reportedQ4 2025
How to read this metric
An increase indicates successful global expansion or favorable international market conditions.
Detailed definition
The portion of pre-tax earnings generated from operations outside the company's home country. This highlights the compan...
Peer comparison
Standard geographic breakdown for multinational firms; highly dependent on global footprint.
Metric ID:
msft_income_before_tax_foreignHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $1.29B | $1.62B | $1.82B |
| YoY Change | — | +25.4% | +12.6% |
Range$1.29B – $1.82B
CAGR+18.8%
Avg YoY Growth+19.0%
Median YoY Growth+19.0%
Current Streak2+ years growth
Pre-Tax Income (Foreign) at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's pre-tax income (foreign)?
- Vertex Pharmaceuticals (VRTX) reported pre-tax income (foreign) of $455.50M in Q4 2025.
- How has Vertex Pharmaceuticals's pre-tax income (foreign) changed year-over-year?
- Vertex Pharmaceuticals's pre-tax income (foreign) increased by 12.6% year-over-year, from $404.55M to $455.50M.
- What is the long-term trend for Vertex Pharmaceuticals's pre-tax income (foreign)?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's pre-tax income (foreign) has grown at a 18.8% compound annual growth rate (CAGR), from $1.29B to $1.82B.
- What does pre-tax income (foreign) mean?
- Pre-tax profit earned specifically from international business operations.